DILH
VPHM

Dai-ichi Life Holdings’s VIROPHARMA INC VPHM Stock Holding History

Dai-ichi Life Holdings’s Portfolio VPHM Stock Details VPHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-34,616
Closed -$1.36M – 689
2013
Q3 		$1.36M Buy
+34,616
New +$1.13M 0.05% 373

Other funds holding VPHM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Dai-ichi Life Holdings's VPHM Position: Q4 2013 in Review

Dai-ichi Life Holdings sold out of VIROPHARMA INC (VPHM) in Q4 2013, closing a stake of 34,616 shares — an estimated $1.36M sold.

Dai-ichi Life Holdings first reported a position in VPHM in Q3 2013 and held it in 1 quarter. The position peaked at $1.36M in Q3 2013. 172 funds tracked by Wall St. Rank hold VPHM as of Q4 2013.

  • Dai-ichi Life Holdings reported no remaining VIROPHARMA INC position as of Q4 2013 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 34,616 VIROPHARMA INC shares in Q4 2013, an estimated $1.36M.
  • Dai-ichi Life Holdings first reported a position in VIROPHARMA INC in Q3 2013 and held it in 1 quarter.
  • Dai-ichi Life Holdings's VIROPHARMA INC position peaked at $1.36M in Q3 2013.
  • 172 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q4 2013.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2013, filed 14 Feb 2014.